European Heart Journal Advance Access originally published online on May 4, 2005
European Heart Journal 2005 26(14):1446-1447; doi:10.1093/eurheartj/ehi316
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org
ASD closure for migraine: is there a scientific basis?: reply
Department of Cardiology
University Hospital Gasthuisberg
Herestraat 49 B
3000 Leuven
Belgium
Tel: +32 16 344235
Fax: +32 16 344240
E-mail address: werner.budts@uz.kuleuven.ac.be
| The first 10% of the full text of this article appears below. |
We greatly appreciate the comments made by Gupta on our paper entitled The influence of percutaneous atrial septal defect closure on the occurrence of migraine.1 However, we have to warn the reader for over-interpreting our findings. With this study, we did not want to prove migraine prevention, but we were